2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$83.73+$0.69 (+0.84%)
Price as of Sep 11, 2026 7:39 PM EDT- $31.3BMarket Cap
- 8.93%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$83.73+$0.69 (+0.84%)
DXCM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $83.03 | ||
Change | -$1.48 (-1.75%) | ||
Open | $84.65 | ||
High | $85.81 | ||
Low | $82.83 | ||
Previous Close | $84.51 | ||
Volume | 2,547,409 | ||
30-Day Average Volume | 3,919,348 | ||
1-Week Change | -5.54% | ||
1-Month Change | -7.26% | ||
1-Year Change | 8.93% | ||
3-Year Change | -22.61% | ||
5-Year Change | -39.55% | ||
Fundamentals | |||
Shares Outstanding | 377.4M | ||
Total Assets | $6.5B | ||
Market Cap | $31.3B | ||
Enterprise Value | $31.5B | ||
Period: QTR TTM FY | |||
Revenue | $1.3B | ||
Net Income | $249.1M | ||
Free Cash Flow | $184.5M | ||
EBIT | $319.7M | ||
EBITDA | $387.9M | ||
Net Working Capital | $1.7B | ||
EPS | $0.64 | ||
Enterprise Value/EBITDA | 81 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 12 | ||
P/E | 130 | ||
PEG | 5 | ||
Price/Free Cash Flow | 170 | ||
Price/Operating Cash Flow | 116 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 4 : 1 | ||
Last Split Date | 06/13/2022 | ||
Earnings & Revenue